Together they promote the development of non‐alcoholic steatohepatitis (NASH) characterized by liver inflammation and activated inflammatory cytokine signaling pathways stimulated by TNF‐α, IL‐1β, KC/CXCL1, MCP1/CCL2, and others.10 Here, CCL2 is linked to metabolic dysfunction-associated steatohepatitis.